Based out of the Pagliuca Harvard Life Lab, BioDevek is a medical device company whose mission is to bring next-generation surgical treatments to the clinic. The company has developed a family of proprietary adhesive materials that adapts to every tissue and condition in the most optimal manner to attain the best clinical outcomes. Their degradable biomaterials can be injected or sprayed onto biological tissues to protect and improve the healing of traditionally sutured or stapled wounds. By engineering the material to degrade at predetermined rates, drugs can be delivered locally over time, improving patient outcomes while eliminating the side effects associated with systemic drug delivery.
Thursday, July 20, 2023
Gonzalo Mūnoz Taboada is the CEO of BioDevek, bringing a strong leadership presence and industry experience to the team. Gonzalo carries an extensive background in biomedical engineering with a Master of Science degree and industrial Ph.D. from IQS Barcelona. He completed his Master’s thesis at MIT, and went on to pursue an MBA and technical entrepreneurship, merging his interests in science, technology, and business. He launched BioDevek in 2017 out of a passion for innovation and dedication to improving healthcare outcomes. A two-time semifinalist in the President's Innovation Challenge, Gonzalo now leads the company as CEO.
One piece of advice to Venturing@Harvard
"At the early stage, pivoting multiple times from your initial idea is common and should not discourage you, but you need to make sure that every change in your plans help you to expand your knowledge and moves the technology forward."